Opinions and debates
Women at the centre of their health
Self-care offers an opportunity to empower patients to manage their own health.
South Africa
Southern Africa needs the right COVID vaccines, at the right price – right now
MSF urges wealthy countries and pharma companies to immediately equitably distribute the right vaccines, at the right price, to low- and middle-income countries.
MSF urges wealthy countries not to block COVID-19 patent waiver
Ahead of the next round of talks at the World Trade Organization (WTO) to discuss a proposal by South Africa and India to waive monopolies on COVID-19 medical tools during the pandemic, MSF called on the wealthy countries opposing the proposal not to block it and ruin its lifesaving potential for billions of people in the rest of the world.
Yemen
“These sanctions have to make clear that they do not apply to humanitarian aid”
As the United States prepares to designate Ansar Allah a 'foreign terrorist organisation' in Yemen, there are concerns about the impact on providing assistance in the country.
MSF's wish list for 2021
Over the past extraordinary year, we were all touched by one of the greatest global health emergencies in decades.
Bangladesh, Myanmar
Case studies and dilemmas around public speaking on the Rohingya people
MSF releases a new Speaking Out Case Study: “MSF and the Rohingya, 1992-2014”.
Governments must support landmark proposal to waive COVID-19 patents
Ahead of World Trade Organization talks to consider a landmark request to waive certain intellectual property during the COVID-19 pandemic – put forward by India and South Africa in October – MSF calls on all governments to support this game-changing step.
5 reasons to refuse patents and monopolies on Covid-19 vaccines
5 reasons a new proposal by India and South Africa could be a gamechanger in the COVID-19 response.
Governments must demand pharma make all COVID-19 vaccine deals public
With billions of dollars of tax payer money being poured into the development coronavirus vaccines, the deals from pharmaceutical companies are being kept largely secret, raising concerns.
Greece
Enough is enough: new pact, same misery for refugees
This op-ed was first published in Geneva Solutions on 3 October 2020.